SCHEMBL7480289

SCHEMBL7480289

CCCCCNc1cc(C)nc(Cl)c1[N+](=O)[O-]

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 1/20 0.45
HCAR3 P49019 2/20 0.43
MAPT P10636 3/20 0.43
L3MBTL1 Q9Y468 2/20 0.42
ALDH1A1 P00352 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.40
NPC1 O15118 1/20 0.40
DNM2 P50570 1/20 0.39
POLB P06746 1/20 0.39
PKM P14618 1/20 0.39
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
KAT2B Q92831 2/20 0.38
RIPK1 Q13546 3/20 0.37
CCNT1 O60563 1/20 0.37
CDK9 P50750 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7480441 0.99 NR4A2 (0.44) NR4A2HCAR3MAPTL3MBTL1ALDH1A1
SCHEMBL2549528 0.82 LMNA (0.52) HCAR3MAPTALDH1A1TDP1SMN1; SMN2
SCHEMBL6098426 0.80 BRD4 (0.47) TDP1
SCHEMBL5827758 0.78 MAPT (0.41) MAPTL3MBTL1ALDH1A1TDP1SMN1; SMN2
SCHEMBL3340185 0.78 MAPT (0.38) HCAR3MAPTL3MBTL1SMN1; SMN2POLB
SCHEMBL7480436 0.78 HCAR3 (0.34) NR4A2HCAR3MAPTL3MBTL1ALDH1A1
SCHEMBL6245357 0.77 KMT2A (0.48) HCAR3MAPTL3MBTL1ALDH1A1TDP1
SCHEMBL413683 0.77 MAPT (0.50) MAPTL3MBTL1ALDH1A1TDP1SMN1; SMN2
SCHEMBL7479132 0.76 CRHR1 (0.36) HCAR3MAPTL3MBTL1ALDH1A1TDP1
SCHEMBL31260423 0.76 LMNA (0.34) MAPTL3MBTL1ALDH1A1TDP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6448261-B1 CORTICOTROPIN RELEASING FACTOR ANTAGONISTS; TREATING ANXIETY, DEPRESSION, AND OTHER PSYCHIATRIC AND NEUROLOGICAL DISORDERS BRISTOL-MYERS SQUIBB PHARMA COMPANY 2002-09-10 US disclosed
EP-0935601-A4 ARYLAMINO FUSED PYRIDINES AND PYRIMIDINES DU PONT PHARM CO (US) 2002-08-07 EP disclosed
US-6107300-A CORTICOTROPIN RELEASING FACTOR ANTAGONIST; PSYCHOLOGICAL DISORDERS DUPONT PHARMACEUTICALS (US) 2000-08-22 US disclosed
EP-0935601-A2 ARYLAMINO FUSED PYRIDINES AND PYRIMIDINES Du Pont Pharmaceuticals Company (US) 1999-08-18 EP disclosed
WO-1997035539-A2 ARYLAMINO FUSED PYRIDINES AND PYRIMIDINES DU PONT PHARMACEUTICALS COMPANY (US) 1997-10-02 WO disclosed